the challenges and potential of triple therapies in non-clear cell rcc
Published 1 year ago • 42 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
0:53
unanswered questions in the management of clear cell rcc
-
5:16
potential new treatments in renal cell carcinoma
-
11:18
first-line icis in advanced non-clear cell rcc
-
1:17
treating non-clear cell renal cell carcinoma patients
-
1:02
non-clear cell sarcamatoid kidney cancer treatment updates
-
1:34
unmet needs in the treatment of renal cell carcinoma
-
1:16
the challenges in treating renal cell carcinoma
-
7:35
non–clear cell rcc treatment
-
5:23
immunotherapy-based management of metastatic clear-cell and variant rcc: what can we achieve?
-
6:57
treating non-clear cell histologies of renal cell carcinoma
-
1:01:05
kcrs21: non clear cell rcc
-
5:11
current treatment landscape for kidney cancer
-
5:18
are combination therapies the future of renal cell carcinoma treatment?
-
4:10
non-clear cell kidney cancer trial updates: calypso and keynote-427
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
1:49
using combination therapy as treatment of non-clear cell rcc
-
2:32
len pembro metastatic clear cell renal cell carcinoma
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer